Species Distribution and Antifungal Susceptibility Profile of Dermatophytes from a Tertiary Care Centre in North India
暂无分享,去创建一个
N. Singla | J. Chander | M. Bhalla | Neelam Gulati | M. Kaur | Swati Sharma | C. Nayyar | M. Kumar | N. Gulati
[1] Priya Uppuluri,et al. A Study of In vitro Antifungal Susceptibility Patterns of Dermatophytic Fungi at a Tertiary Care Center in Western India , 2019, Indian journal of dermatology.
[2] U. Saikia,et al. A prospective study of the epidemiological and clinical patterns of recurrent dermatophytosis at a tertiary care hospital in India , 2018, Indian journal of dermatology, venereology and leprology.
[3] A. Bitew. Dermatophytosis: Prevalence of Dermatophytes and Non-Dermatophyte Fungi from Patients Attending Arsho Advanced Medical Laboratory, Addis Ababa, Ethiopia , 2018, Dermatology research and practice.
[4] V. Pai,et al. Antifungal Resistance in Dermatology , 2018, Indian journal of dermatology.
[5] Smital Kulkarni,et al. In vitro susceptibility testing of four antifungal drugs against fungal isolates in onychomycosis , 2018, International Journal of Research in Medical Sciences.
[6] Z. Salehi,et al. Antifungal drug susceptibility profile of clinically important dermatophytes and determination of point mutations in terbinafine-resistant isolates , 2018, European Journal of Clinical Microbiology & Infectious Diseases.
[7] Ayşe Barış,et al. In vitro susceptibility of seven antifungal agents against dermatophytes isolated in İstanbul , 2018, Turkish journal of medical sciences.
[8] S. Dogra,et al. Newer Topical Treatments in Skin and Nail Dermatophyte Infections , 2018, Indian dermatology online journal.
[9] Ashutosh Kumar Singh,et al. High terbinafine resistance in Trichophyton interdigitale isolates in Delhi, India harbouring mutations in the squalene epoxidase gene , 2018, Mycoses.
[10] Saurabh Sharma,et al. Antifungal susceptibility pattern of dermatomycosis in a tertiary care hospital of North India , 2018 .
[11] S. Dogra,et al. Mutation in the Squalene Epoxidase Gene of Trichophyton interdigitale and Trichophyton rubrum Associated with Allylamine Resistance , 2018, Antimicrobial Agents and Chemotherapy.
[12] P. Arora,et al. Is Antifungal Resistance a Cause for Treatment Failure in Dermatophytosis: A Study Focused on Tinea Corporis and Cruris from a Tertiary Centre? , 2018, Indian dermatology online journal.
[13] Rekha Sharma,et al. Recurrent dermatophytosis: A rising problem in Sikkim, a Himalayan state of India , 2017, Indian journal of pathology & microbiology.
[14] S. Dogra,et al. Treatment of Dermatophytosis in Elderly, Children, and Pregnant Women , 2017, Indian dermatology online journal.
[15] Thai D. Nguyen,et al. Distribution of Species of Dermatophyte Among Patients at a Dermatology Centre of Nghean Province, Vietnam, 2015–2016 , 2017, Mycopathologia.
[16] M. Mokni,et al. Prevalence, Etiology, and Risk Factors of Tinea Pedis and Tinea Unguium in Tunisia , 2017, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.
[17] S. Verma,et al. The Great Indian Epidemic of Superficial Dermatophytosis: An Appraisal , 2017, Indian journal of dermatology.
[18] Gagandeep Singh,et al. Molecular Identification and Antifungal Susceptibility Patterns of Clinical Dermatophytes Following CLSI and EUCAST Guidelines , 2017, Journal of fungi.
[19] A. Inamadar,et al. Clinical failure of antifungal therapy of dermatophytoses: Recurrence, resistance, and remedy , 2017 .
[20] A. Kindo,et al. Incidence and prevalence of dermatophytosis in and around Chennai, Tamilnadu, India , 2016 .
[21] A. Sahoo,et al. Management of tinea corporis, tinea cruris, and tinea pedis: A comprehensive review , 2016, Indian dermatology online journal.
[22] H. Badali,et al. Molecular Characterization and In Vitro Antifungal Susceptibility of 316 Clinical Isolates of Dermatophytes in Iran , 2016, Mycopathologia.
[23] P. Sharma,et al. Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method , 2015, Indian journal of medical microbiology.
[24] Lakshmi Vasantha Poluri,et al. Clinicomycological Study of Dermatophytosis in South India , 2015, Journal of laboratory physicians.
[25] H. Badali,et al. In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs , 2015, Mycoses.
[26] S. Seyedmousavi,et al. Comparison of the In Vitro Activities of Newer Triazoles and Established Antifungal Agents against Trichophyton rubrum , 2015, Antimicrobial Agents and Chemotherapy.
[27] A. Lakshmanan,et al. Epidemiological and clinical pattern of dermatomycoses in rural India , 2015, Indian journal of medical microbiology.
[28] N. L. Sharma,et al. Mycological Pattern of Dermatophytosis in and Around Shimla Hills , 2014, Indian journal of dermatology.
[29] R. Boloor,et al. A Clinical and Mycological Study of Dermatophytic Infections , 2014, Indian journal of dermatology.
[30] P. Sharma,et al. Epidemiological studies on Dermatophytosis in human patients in Himachal Pradesh, India , 2014, SpringerPlus.
[31] Y. Bulut,et al. In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey , 2013, International journal of dermatology.
[32] S. Hashemi,et al. In-vitro Activity of 10 Antifungal Agents against 320 Dermatophyte Strains Using Microdilution Method in Tehran , 2013, Iranian journal of pharmaceutical research : IJPR.
[33] Roberto Arenas,et al. Tinea incognito. , 2010, Clinics in dermatology.
[34] Maria R R Silva,et al. In vitro susceptibility testing of dermatophytes isolated in Goiania, Brazil, against five antifungal agents by broth microdilution method. , 2009, Revista do Instituto de Medicina Tropical de Sao Paulo.
[35] M. Pihet,et al. Conventional Methods for the Diagnosis of Dermatophytosis , 2008, Mycopathologia.
[36] Clinical,et al. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi : Approved standard , 2008 .
[37] Aditya K. Gupta,et al. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity , 2003, The British journal of dermatology.
[38] H. Zaun,et al. Treatment of toenail onychomycosis. A randomized, double-blind study with terbinafine and griseofulvin. LAGOS II Study Group. , 1995, Archives of dermatology.